MAOB and Alzheimer disease: If MAO-B upregulation by reactive astrocytes is confirmed to promote neurodegeneration as suggested by preclinical studies [13, 26, 49, 52], MAO-B inhibition could have therapeutic value to slow down AD/ADRD progression.